Dr Robert Motzer, Genitourinary Oncol Service, Memorial Sloan-Kettering Cancer Center, New York/USA
Channel: Oncoletter
Date: 2012-10-01

Vienna, ESMO 2012, Pressconference October 1:
Dr Robert Motzer, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York/UNITED STATES OF AMERICA: Randomized, Open label, Phase III Trial of Pazopanib versus Sunitinib in First-line Treatment of Patients with Metastatic Renal Cell Carcinoma (mRCC); Results of the COMPARZ Trial